Cyclerion Therapeutics (CYCN) Earnings Date & Reports

A.I. Advisor

published Earnings

CYCN is expected to report earnings to rise 75.00% to -28 cents per share on August 08

Cyclerion Therapeutics CYCN Stock Earnings Reports

Q2'23

Est.

$-0.28

Q1'23

Beat

by $0.14

Q4'22

Beat

by $0.12

Q3'22

Beat

by $5.96

Q2'22

Missed

by $0.01

The last earnings report on May 11 showed earnings per share of -15 cents, beating the estimate of -30 cents. With 10.10K shares outstanding, the current market capitalization sits at 6.58M.

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of pharmaceutical products for serious and orphan diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

245 First Street

Phone

+1 857 327-8778

Employees

Web

https://www.cyclerion.com